Healthcare, Financials, Automotive Jan 27, 2022 01:49 PM (GMT+8) · EqualOcean
Small activated RNA drug development enterprise "Zhongmei Ruikang" recently completed nearly 200 million yuan of a + round of financing. This round of financing is led by SDIC and followed by multinational pharmaceutical enterprises Japan Weicai, Lingcheng venture capital, China Singapore capital and Xianghe Chengdao. This round of financing is mainly used to promote several preclinical projects to the clinical stage, expand nucleic acid production capacity and accelerate the internationalization process.

This text is a result of machine translation.